Chronic Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy Combined With Diuretic Therapy is Associated With Increased Episodes of Hypotension in Noncardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 2, 2008, Pages 180-186

  Kheterpal, Sachin ^a   Khodaparast, Omeed ^b   Shanks, Amy ^a   O'Reilly, Michael ^a   Tremper, Kevin K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

angiotensin converting enzyme inhibitor; diuretics; intraoperative hypotension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPERTENSIVE FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIURETIC THERAPY; GENERAL ANESTHESIA; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MONOTHERAPY; OBSERVATIONAL STUDY; POPULATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

ANESTHESIA, GENERAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; DIURETICS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; HYPOTENSION; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 41049118579     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.12.020     Document Type: Article

References (32)

1. Bertrand M., Godet G., Meersschaert K., et al. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 92 (2001) 26-30
2. Brabant S.M., Bertrand M., Eyraud D., et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 89 (1999) 1388-1392
3. Brabant S.M., Eyraud D., Bertrand M., et al. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists. Anesth Analg 89 (1999) 887-888
4. Colson P., Ribstein J., Mimran A., et al. Effect of angiotensin-converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 72 (1990) 23-27
5. Colson P., Saussine M., Seguin J.R., et al. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 74 (1992) 805-808
6. Eyraud D., Brabant S., Nathalie D., et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 88 (1999) 980-984
7. Licker M., Schweizer A., Hohn L., et al. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth 47 (2000) 433-440
8. Medel J., Boccara G., Van de Steen E., et al. Terlipressin for treating intraoperative hypotension: Can it unmask myocardial ischemia?. Anesth Analg 93 (2001) 53-55
9. Ryckwaert F., and Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 84 (1997) 945-949
10. Tuman K.J., McCarthy R.J., O'Connor C.J., et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 80 (1995) 473-479
11. Comfere T., Sprung J., Kumar M.M., et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 100 (2005) 636-644
12. Haber E. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 54 (1976) 849-861
13. Sancho J., Re R., Burton J., et al. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 53 (1976) 400-405
14. Behnia R., Molteni A., and Igic R. Angiotensin-converting enzyme inhibitors: Mechanisms of action and implications in anesthesia practice. Curr Pharm Des 9 (2003) 763-776
15. Reich D.L., Hossain S., Krol M., et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 101 (2005) 622-628
16. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
17. Aronoff G., Berns J., and Brier M. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults. (ed 4) (1999), American College of Physicians, Philadelphia, PA 176
18. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
19. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 17 (1998) 2265-2281
20. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
21. Kellow N.H. The renin-angiotensin system and angiotensin-converting enzyme (ACE) inhibitors. Anaesthesia 49 (1994) 613-622
22. Colson P., Ryckwaert F., and Coriat P. Renin-angiotensin system antagonists and anesthesia. Anesth Analg 89 (1999) 1143-1155
23. Talbot M.P., Tremblay I., Denault A.Y., et al. Vasopressin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg 120 (2000) 401-402
24. Pappalardo F., Landoni G., Franco A., et al. Prolonged refractory hypotension in cardiac surgery after institution of cardiopulmonary bypass. J Cardiothorac Vasc Anesth 16 (2002) 477-479
25. Sparicio D., Landoni G., and Zangrillo A. Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue. J Thorac Cardiovasc Surg 127 (2004) 608
26. Pigott D.W., Nagle C., Allman K., et al. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 83 (1999) 715-720
27. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
28. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
29. Rose B.D., and Post T.W. Clinical Physiology of Acid-Base and Electrolyte Disorders (2001), McGraw-Hill, New York, NY 961
30. Bijker J.B., van Klei W.A., Kappen T.H., et al. Incidence of intraoperative hypotension as a function of the chosen definition: Literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107 (2007) 213-220
31. Warner M.A., and Monk T.G. The impact of lack of standardized definitions on the specialty. Anesthesiology 107 (2007) 198-199
32. Monk T.G., Saini V., Weldon B.C., et al. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 100 (2005) 4-10